Paediatric Bridge to Transplant

29 July 2025

The PVRI Lung Transplantation in Pulmonary Hypertension Workstream presented a webinar on expert strategies for bridging paediatric patients to lung transplant. 

This dynamic session featured focused presentations on mechanical support strategies for paediatric bridge to lung transplant across the lifespan—from infancy to adolescence—highlighting how each expert’s practice has evolved, and concluding with interactive, case-based discussions.

Featuring

  • Ryan Coleman, Texas Children’s Hospital, USA (speaker)
  • Pirooz Eghtesady, Washington University in St. Louis, USA (speaker)
  • Darren Freed, University of Alberta, Canada (speaker)
  • Rebecca Kameny, Stanford University, USA (moderator)
  • Melinda Solomon, University of Toronto, Canada (moderator)

Speakers & moderators

Ryan Coleman, Texas Children’s Hospital, USA
Pirooz Eghtesady, Washington University in St. Louis, USA
Darren Freed, University of Alberta, Canada
Rebecca Kameny, Stanford University, USA
Melinda Solomon, University of Toronto, Canada
Share:

Other materials on this topic

1 December 2025

Beyond Resistance: Pulmonary Vascular Compromise as a Mechanistic Window Into Pediatric Pulmonary Hypertension

In the recent paper, Pulmonary Vascular Compromise is Associated with Survival in Pediatric Pulmonary Hypertension: a New Computational Model by Niccum et al. [1] presents an innovative computational model reframing pulmonary vascular disease through the concept of pulmonary vascular compromise (PVC), a quantifiable estimate of the proportion of pulmonary vascular surface area lost relative to an idealized normal pulmonary vascular capacity.

Pulmonary Circulation
14 November 2025

Challenges of Developing Novel Therapies for Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension

This webinar brings together leading experts to explore the urgent need for new therapies in bronchopulmonary dysplasia-associated pulmonary hypertension. You’ll gain a clear overview of current care, key research gaps, and the real-world challenges of designing meaningful trials for preterm infants — all aimed at advancing treatment for this under-recognised condition.

Members Only

More from IDDI Workstream and Task Force Learning

Show more details

Our IDDI Workstreams & Task Forces are actively finding practical solutions to the key challenges facing Pulmonary Hypertension (PH) physicians, academics, industry, and regulators; raising awareness of Pulmonary Vascular Disease (PVD); and addressing key challenges in its causes, effects, and treatment. 

Hipertensión Pulmonar Grupo 2: asociada a insuficiencia cardiaca y retención de fluido
Microbes/Parasites and Sex Differences in PVDs - iPVD Virtual Symposium Series
SAPH 2026
Iron and High Altitude
Pulmonary Hypertension in Latin America
6th Paediatric & 3rd Adult LATAM PH Symposium
Women’s Health and Pulmonary Vascular Disease
From Patient Voices to Action: Understanding the PH Global Survey
Pulmonary Hypertension in the Shadow of Infections: Challenges in Indian Practice - iPVD Virtual Symposium Series
Phenotypes and treatment strategies for pulmonary hypertension in interstitial lung disease
Debunking myths about lung transplantation for PH – A webinar for patients and caregivers
Inhaled Treprostinil in pulmonary hypertension associated with interstitial lung disease: hope on the horizon
Tobacco smoking as risk for pulmonary hypertension
Evolving technology for monitoring and measuring physical activity via accelerometry in patients with pulmonary hypertension
Pulmonary hypertension in COPD an unmet clinical need